# Efficacy and Tolerability of the APD Treatment in PAED Patients

> **NCT07004907** · NA · NOT_YET_RECRUITING · sponsor: **Fresenius Medical Care Deutschland GmbH** · enrollment: 13 (estimated)

## Conditions studied

- Renal Failure Acute Chronic

## Interventions

- **DEVICE:** Treatment with the pedriatic mode of the APD cycler

## Key facts

- **NCT ID:** NCT07004907
- **Lead sponsor:** Fresenius Medical Care Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004907, "Efficacy and Tolerability of the APD Treatment in PAED Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07004907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*